Back to Search
ROBERT CALIFF, M.D.
M.D.
Cardiovascular Disease Physician
NPI: 1619051331Individual
Specialties, Licenses & Credentials
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
26208(NC)
Research & Publications (20)
Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
PMID 19576338·Am J Cardiol·2009
2-rct
Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
PMID 18946890·Am Heart J·2008
4-observational
The balance of benefit and safety of rosiglitazone: important lessons for our system of drug development and postmarketing assessment.
PMID 18655016·Pharmacoepidemiol Drug Saf·2008
8-other
Considerations of net present value in policy making regarding diagnostic and therapeutic technologies.
PMID 19061701·Am Heart J·2008
8-other
Benefit assessment of therapeutic products: the Centers for Education and Research on Therapeutics.
PMID 16506270·Pharmacoepidemiol Drug Saf·2007
6-review
Evaluation of diagnostic imaging technologies and therapeutics devices: better information for better decisions: proceedings of a multidisciplinary workshop.
PMID 16824831·Am Heart J·2006
8-other
Clinical trials bureaucracy: unintended consequences of well-intentioned policy.
PMID 17170032·Clin Trials·2006
8-other
A perspective on trials comparing enoxaparin and unfractionated heparin in the treatment of non-ST-elevation acute coronary syndromes.
PMID 16124953·Am Heart J·2005
8-other
A time of accelerated change in academic cardiovascular medicine: implications for academic divisions of cardiology and their training programs.
PMID 15542276·J Am Coll Cardiol·2004
8-other
Benefit the patient, manage the risk: a system goal.
PMID 15133777·Pharmacoepidemiol Drug Saf·2004
6-review
Health Insurance Portability and Accountability Act (HIPAA): must there be a trade-off between privacy and quality of health care, or can we advance both?
PMID 12939241·Circulation·2003
6-review
Toward protecting the safety of participants in clinical trials.
PMID 12757992·Control Clin Trials·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2100 ERWIN RD
DURHAM, NC 27705 - Phone
- (919) 684-8111
Quick Facts
- NPI
- 1619051331
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile